| KMT2A |
Q03164
|
lysine methyltransferase 2A
|
|
1.00 |
0.410 |
0.885 |
| APOB |
P04114
|
apolipoprotein B
|
|
1.9E-16 |
0.453 |
0.808 |
| HBB |
P68871
|
hemoglobin subunit beta
|
|
1.2E-09 |
0.494 |
0.808 |
| SCD |
O00767
|
stearoyl-CoA desaturase
|
|
0.97 |
0.490 |
0.808 |
| CDH23 |
Q9H251
|
cadherin related 23
|
|
3.2E-06 |
0.539 |
0.769 |
| DBH |
P09172
|
dopamine beta-hydroxylase
|
|
3.3E-10 |
0.511 |
0.846 |
| RN7SL263P |
|
RNA, 7SL, cytoplasmic 263, pseudogene
|
|
|
0.496 |
0.808 |
| CD55 |
P08174
|
CD55 molecule (Cromer blood group)
|
|
5.7E-12 |
0.510 |
0.808 |
| FAAH |
O00519
|
fatty acid amide hydrolase
|
|
4.4E-11 |
0.545 |
0.692 |
| HMGCR |
P04035
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
1.00 |
0.529 |
0.692 |
| DLL3 |
Q9NYJ7
|
delta like canonical Notch ligand 3
|
|
5.4E-05 |
0.552 |
0.654 |
| BRAP |
Q7Z569
|
BRCA1 associated protein
|
|
3.8E-06 |
0.612 |
0.769 |
| ABHD5 |
Q8WTS1
|
abhydrolase domain containing 5
|
|
6.4E-07 |
0.641 |
0.538 |
| MESP2 |
Q0VG99
|
mesoderm posterior bHLH transcription factor 2
|
|
3.1E-06 |
0.653 |
0.462 |
| ZFYVE9 |
O95405
|
zinc finger FYVE-type containing 9
|
|
0.90 |
0.647 |
0.615 |
| MADD |
Q8WXG6
|
MAP kinase activating death domain
|
|
1.5E-14 |
0.644 |
0.538 |
| RIPPLY2 |
Q5TAB7
|
ripply transcriptional repressor 2
|
|
9.4E-03 |
0.650 |
0.462 |
| SCD5 |
Q86SK9
|
stearoyl-CoA desaturase 5
|
|
1.0E-03 |
0.682 |
0.654 |
| BEAN1 |
Q3B7T3
|
brain expressed associated with NEDD4 1
|
|
6.8E-06 |
0.705 |
0.385 |
| INSIG1 |
O15503
|
insulin induced gene 1
|
|
1.3E-03 |
0.695 |
0.500 |
| MIR3936HG |
|
MIR3936 host gene
|
|
|
0.861 |
0.269 |
| SAR1A |
Q9NR31
|
secretion associated Ras related GTPase 1A
|
|
0.37 |
0.743 |
0.538 |
| DAGLA |
Q9Y4D2
|
diacylglycerol lipase alpha
|
|
1.00 |
0.821 |
0.308 |
| DAGLB |
Q8NCG7
|
diacylglycerol lipase beta
|
|
2.6E-12 |
0.931 |
0.154 |
| CHKB-CPT1B |
|
CHKB-CPT1B readthrough (NMD candidate)
|
|
|
0.769 |
0.385 |